20305 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
ORAL SUPPLEMENT FOR CELLULAR METABOLIC FITNESS
#2Fertility Enhancement Composition
#3Composition for Activating Transient Receptor Potential Ankyrin 1, and Composition for Enhancing Food Consumption and/or Ameliorating Decreased Appetite
#4TREATING PAIN ASSOCIATED WITH CENTRAL SENSITIZATION
#5ADMINISTRATION OF GLUTATHIONE TRISULFIDE TO AMELIORATE PERIPHERAL NEUROPATHY
#6COMPOUNDS AND METHODS FOR THE TREATMENT OF DERMAL AND OCULAR DISORDERS
#7FACE AND BODY OIL COMPOSITION
#8PET FOOD SUPPLEMENT COMPOSITION
#9Method for Treating Lysosomal Storage Disease
#10COMPOSITIONS AND METHODS FOR SKIN CARE
#11DELIVERY SYSTEM
#12INTRANASAL ADMINISTRATION OF POLYSULFIDE
#13COMPOSITION COMPRISING ALOX5 INHIBITOR FOR PREVENTING OR TREATING SARCOPENIA
#14A SYSTEM AND METHOD FOR COMPARTMENTALIZED INGREDIENTS FOR A LIQUID PHARMACEUTICAL FORMULATION
#15COMPOSITIONS FOR PREVENTING TRANSITION FROM ACUTE TO CHRONIC PAIN
#16PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING OSTEOARTHRITIS
#17COMBINATIONS OF VITAMIN D3, NIACINAMIDE AND LIPOIC ACID FOR USE IN THE MAINTENANCE OF HEALTHY BLOOD GLUCOSE LEVELS
#18CELL DIFFERENTIATION
#19COMPOSITIONS COMPRISING BUTYRIC ACID AND GLUCONIC ACID FOR THE TREATMENT OF DISORDERS AND SYNDROMES ASSOCIATED WITH INTESTINAL BARRIER DYSFUNCTIONS AND DYSBIOSIS
#20ORALLY ADMINISTRABLE COMPOSITIONS COMPRISING AVOCADO/SOYBEAN UNSAPONIFIABLES AND LIPOIC ACID AND METHODS OF ADMINISTRATION
#21COMPOSITIONS COMPRISING MIXTURES OF COMPOUNDS AND USES THEREOF
#22TETHERING CYSTEINE RESIDUES USING CYCLIC DISULFIDES
#23COMPOSITIONS
#24COMPOSITIONS AND METHODS FOR TREATMENT OF HOMOCYSTINURIA
#25METHODS FOR THE TREATMENT OF CONDITIONS RELATED TO HYDROGEN SULFIDE
#26METHOD OF TREATING CANCER WITH COMBINATIONS OF HISTONE DEACETYLASE INHIBITORS (HDACI) SUBSTANCES
#27NOVEL TETRAHYDROCURCUMIN COMPOSITIONS, METHODS OF MAKING, AND METHODS OF USING THE SAME
#28CARRIER OR AUXILIARY MATERIAL OF OPHTHALMIC PREPARATION, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF
#29COMPOSITION OF BEVERAGE CONCENTRATE CONTAINING CITRIC ACID AND NATURAL ANTIOXIDANT
#30PET SHAMPOOS, PET FOOD COMPOSITIONS, AND REGIMENS AND/OR METHODS THEREOF
#31SYSTEMS AND METHODS FOR TREATMENT OF HEARING USING DIHEXA
#32PHARMACEUTICAL COMPOSITIONS COMPRISING GLITAZONES AND NRF2 ACTIVATORS
#33IDEBENONE DERIVATIVES AND THEIR USE IN TREATING PLANTS
#34PAIN-RELIEF MEDICINE FOR HEADACHE
#35DRUG FOR REDUCING BLOOD GLUCOSE AND/OR TREATING DIABETIC COMPLICATIONS
#36Methods and Compositions for the Treatment of Cytoplasmic Glycogen Storage Disorders
#37METHOD FOR PREVENTING NITRATION OF TYROSINE RESIDUES IN HEPATOCYTE GROWTH FACTOR USING TRISULFIDE COMPOUND
#38Tethering Cysteine Residues Using Cyclic Disulfides
#39COMPOSITIONS AND METHODS FOR PAIN RELIEF
#40ANETHOLE TRITHIONE FOR THE TREATMENT OF VASCULITIDES
#41TETRAHYDROCURCUMINOID-METAL COMPLEXES, MANUFACTURING METHODS THEREOF, AND USES THEREOF
#42PROPHYLACTIC OR THERAPEUTIC DRUG FOR PARKINSON'S DISEASE
#43COMPOSITIONS COMPRISING ORGANIC MINERAL CHELATES, NIACINAMIDE, AND HEMP OIL AND USES THEREOF FOR NEUROPROTECTION, CARDIOPROTECTION, DETOXIFICATION, IMMUNE SUPPORT, AND ANTI-AGING
#44COMPOSITION COMPRISING LIPOIC ACID AND VITAMIN D FOR THE PREVENTION AND THE TREATMENT OF NEURODEGENERATIVE DISEASES AND PERIPHERAL NEUROPATHIES
#45Treatment for Down Syndrome-Related Accelerated Aging
#46Liver Vitality
#47BIO-ERODIBLE OCULAR IMPLANTS FOR TREATMENT OF CONDITIONS OF THE EYE
#48IONIC LIQUID FORMULATIONS FOR TREATING DIABETES
#49PERSONALIZED MULTIDISCIPLINARY CANCER THERAPY
#50Compositions and methods for treatment of homocystinuria
#51COMPOSITION FOR TREATING AND/OR PREVENTING A HANGOVER
#52METHODS OF TREATING NEURODEGENERATIVE DISORDERS AND STAT3-LINKED CANCERS USING SUPPRESSORS OF ELECTRON LEAK
#53Nutritional Formulas Comprising Medium Chain Fatty Acids or Esters Thereof and Methods Related Thereto
#54PRECISION CANNABINOID THERAPY FORMULATIONS AND METHODS OF USE
#55ANETHOLE TRITHIONE ADMINISTRATION REGIMEN FOR THE PREVENTION OR TREATMENT OF ISCHEMIA-REPERFUSION INJURIES
#56COMPOSITIONS AND METHODS FOR TREATMENT AND PROPHYLAXIS OF VIRAL INFECTIONS
#57TECHNIQUES FOR TRAVERSING DATA EMPLOYED IN RAY TRACING
#58COMPOSITIONS AND METHODS FOR PROMOTING CELLULAR METABOLIC FITNESS
#59MULTICOMPONENT COMPOSITION AND USE THEREOF IN THE TREATMENT OF PROSTATE DISEASES
#60USE OF SLOW-RELEASING HYDROGEN SULFIDE ORGANIC DONOR ADT-OH IN THE PREPARATION OF DRUGS FOR TREATING NERVOUS SYSTEM DISEASES
#61SULFUR-CONTAINING COMPOUND USEFUL FOR TREATING OR PREVENTING PRESBYOPIA
#62Compositions and Methods for Treatment of Prediabetes
#63COMBINATION OF AN ANTIMUSCARINIC OR AN ANTICHOLINERGIC AGENT AND LIPOIC ACID AND USES THEREOF
#64DELIVERY SYSTEM
#65Brain Targeted Nutritional Therapeutic for Improved Cognitive Function and Treatment of Mild Cognitive Impairment
#66COMPOSITIONS AND METHODS FOR IMPROVING GUT HEALTH
#67Method for stabilization and delivery of therapeutic molecules
#68Compositions and Methods for Gene Therapy for Corneal Endothelium Disorders
#69Methods and compositions for the treatment of steatosis-associated disorders
#70Methods and Compositions for the Treatment of Steatosis-Associated Disorders
#71Compositions comprising mixtures of compounds and uses thereof
#72ENHANCED MITOCHONDRIAL RESPONSE WITH THIOZOLIDINEDIONE, PIOGLITAZONE OR ROSIGLITAZONE
#73CONTACT LENS PRODUCT WITH CORNEA REPAIR FUNCTION
#74SOLID ORAL COMPOSITIONS COMPRISING COMPOSITE MONOLITHIC MATRICES FOR CHRONOTROPIC ADMINISTRATION OF ACTIVE INGREDIENTS IN THE GASTROINTESTINAL TRACT
#75METHOD OF DIAGNOSING MITOCHONDRIAL DNA DISORDERS USING STOOL SAMPLES
#76CYSTEAMINE PRECURSOR COMPOUNDS FOR THE TREATMENT OF BETACORONAVIRUS INFECTIONS
#77METHODS OF ANTIPATHOGENIC TREATMENT
#78Pharmaceutical compositions comprising glitazones and Nrf2 activators
#79ALPHA LIPOIC ACID, EPIGALLOCATECHIN 3-GALLATE, AND CURCUMIN AS A MEDICAMENT FOR THE TREATMENT OF ARTHRITIS AND SARS-COV-2
#80LIPOIC ACID CHOLINE ESTER COMPOSITIONS AND METHODS TO STABILIZE INTO PHARMACEUTICALLY RELEVANT DRUG PRODUCTS
#81Microdaily-children gummy for optimal growth, development, and health
#82NOVEL SMALL MOLECULE ANTICANCER AGENTS, COMBINATIONS AND USES THEREOF
#83COMPOSITIONS AND METHODS FOR PROMOTING CELLULAR METABOLIC FITNESS
#84COMPOSITIONS FOR PREVENTION OF SIDE EFFECTS RELATED TO ALCOHOL CONSUMPTION
#85TREATMENT OF ADDICTION AND IMPULSE-CONTROL DISORDERS USING PDE7 INHIBITORS
#86COMBINATION OF ANETHOLE TRITHIONE OR ITS DERIVATIVE, 4-OH-ANETHOLE TRITHIONE, WITH DOXYCYCLINE OR MINOCYCLINE FOR THE USE THEREOF IN THE TREATMENT OF PARKINSON'S DISEASE
#87TETHERING CYSTEINE RESIDUES USING CYCLIC DISULFIDES
#88COMPOSITION AND METHOD FOR MODULATING HYDROGEN ION PHYSIOLOGY RELATED TO BRAIN HEALTH COMPONENT
#89COMPOSITIONS AND METHODS FOR TREATMENT OF HOMOCYSTINURIA
#90METHODS FOR TREATMENT OF DAMAGED BILIARY DUCT
#91NAD-PRECURSORS AND DIETARY RESTRICTION FOR TREATING AGE RELATED MEDICAL CONDITIONS
#92FORMULATION TO REDUCE OR PREVENT OXIDATIVE STRESS DAMAGE
#93Compositions comprising mixtures of compounds and uses thereof
#94Method for stabilization and delivery of therapeutic molecules
#95METHODS AND COMPOSITIONS FOR THE TREATMENT OF PRE-DIABETES, DIABETES AND METABOLIC SYNDROME
#96Compositions And Methods For Treating Traumatic Brain Injury
#97Edible Formulations Based on Active Ingredients and Arginine
#98Composition comprising lipoic acid and vitamin D for the prevention and the treatment of neurodegenerative diseases and peripheral neuropathies
#99CANCER THERAPY
#100LIPOIC ACID PRODRUG
#101Choline Esters
#102Tethering cysteine residues using cyclic disulfides
#103Compositions and methods for treatment of homocystinuria
#104INJECTABLE COMPOSITION FOR INDUCING LIPOLYSIS AND METHOD USING THE SAME
#105CANNABIS TIME RELEASE APPARATUS AND METHOD OF MANUFACTURE THEREOF
#106MULTI-SUPPLEMENT COMPOSITIONS
#107USE OF PPAR-DELTA AGONISTS IN THE TREATMENT OF MITOCHONDRIAL MYOPATHY
#108METHODS AND MATERIALS FOR TREATING DIABETES OR LIVER STEATOSIS
#109COMBINATION OF SELECTIVE ALPHA-ADRENERGIC RECEPTOR AGONIST OR AN ANTICHOLINERGIC AGENT AND LIPOIC ACID AND USES THEREOF
#110LIPOIC ACID CHOLINE ESTER COMPOSITIONS AND METHODS TO GENERATE BIOCOMPATIBLE OPHTHALMIC FORMULATIONS
#111Use of System XC-Inhibitor for Treating Statin-Induced Myalgia
#112Weight management composition
#113Treatment of Addiction and Impulse-Control Disorders Using PDE7 Inhibitors
#114High-dose antioxidants in cancer treatment
#115MUSCLE TREATMENT COMPOSITION AND METHOD OF MAKING SAME
#116Methods and compositions for the treatment of cytoplasmic glycogen storage disorders
#117Compound for treating oxidative stress in mammals
#118USE OF A PPAR-DELTA AGONIST IN THE TREATMENT OF FATTY ACID OXIDATION DISORDERS (FAOD)
#119Methods for the treatment of conditions related to hydrogen sulfide
#120Pharmaceutical composition to treat health conditions associated with elevated glucose levels
#121TREATING MALE INFERTILITY SECONDARY TO SPERM OXIDATIVE STRESS
#122Method of treating cancer with combinations of histone deacetylase inhibitors (HDAC1) substances
#123COMPOSITIONS FOR MENTAL ALERTNESS AND METHODS OF MAKING AND USING THEREOF
#124HEALTH MANAGEMENT COMPOSITIONS AND METHODS OF MAKING AND USING THEREOF
#125TETRAHYDROCURCUMINOID-METAL COMPLEXES, MANUFACTURING METHODS THEREOF, AND USES THEREOF
#126Compositions and methods for pain relief
#127Pharmaceutical composition comprising cyclodextrin complexes of anethole trithione or derivatives thereof
#128PHARMACEUTICAL USE
#129NOVEL TETRAHYDROCURCUMIN COMPOSITIONS, METHODS OF MAKING, AND METHODS OF USING THE SAME
#130ORAL FORMULATIONS FOR PROMOTING CELLULAR PURIFICATION
#131ALA AND SALT FORMULATION
#132Nutritional formulas comprising medium chain fatty acids or esters thereof and methods related thereto
#133Compounds for inhibition of inflammation
#134MELATONIN FOR PREVENTING AND TREATING RADIATION VAGINITIS AND PROCTITIS
#135NOVEL NARINGENIN/LIPOIC ACID CONJUGATE COMPOUND AND USE THEREOF
#136Formulations for reducing anxiety in non-human mammals by increasing brain serotonin levels
#137Methods and Compositions for Delivering Retinaldehyde to a Topical Location of a Subject
#138Methods and compositions for the treatment of steatosis-associated disorders
#139SUSTAINED RELEASE LINGUAL THIOCTIC ACID DELIVERY SYSTEMS
#140COMPOSITIONS COMPRISING ORGANIC MINERAL CHELATES, NIACINAMIDE, AND HEMP OIL AND USES THEREOF FOR NEUROPROTECTION, CARDIOPROTECTION, DETOXIFICATION, IMMUNE SUPPORT, AND ANTI-AGING
#141Composition and method for rapidly inducing an endogenous ketosis
#142COMPOSITIONS AND METHODS FOR ACTIVATING CELLULAR SIGNALING PATHWAYS
#143COMPOSITIONS AND METHODS FOR ACTIVATING CELLULAR SIGNALING PATHWAYS
#144Compositions and methods for activating cellular signaling pathways
#145COMPOSITIONS AND METHODS FOR ACTIVATING CELLULAR SIGNALING PATHWAYS
#146PREVENTION AND/OR TREATMENT OF CHRONIC FATIGUE SYNDROME
#147COMPOUND FOR TREATING OXIDATIVE STRESS IN MAMMALS
#148Desmethylanethole trithione derivatives for the treatment of diseases linked to mitochondrial reactive oxygen species (ROS) production
#149Small molecule anticancer agents, combinations and uses thereof
#150Radioprotection, Radiomitigation and Radiorecovery
#151ANTITUMOR NANO-DRUG
#152Method for preventing or treating hangover symptom(s) associated with consumption of alcoholic beverage(s)
#153H2S-BASED THERAPEUTIC AGENTS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
#154Prevention of the risks associated with drug-induced QT interval prolongation by using a specific inhibitor of the production of ROS of miochondrial origin
#155USE OF CALORIC RESTRICTION MIMETICS FOR POTENTIATING CHEMO-IMMUNOTHERAPY FOR THE TREATMENT OF CANCERS
#156COMPOSITIONS
#157OPHTHALMIC PRODUCT WITH CORNEA REPAIR FUNCTION
#158Compositions for Improved Neuroprotective Effects and Methods of Making Same
#159LIPOIC ACID FORMULATIONS
#160COMBINATION OF AN ANTIMUSCARINIC OR AN ANTICHOLINERGIC AGENT AND LIPOIC ACID AND USES THEREOF
#161LIPOIC ACID CHOLINE ESTER COMPOSITIONS AND METHODS TO GENERATE BIOCOMPATIBLE OPHTHALMIC FORMULATIONS
#162Compositions and methods for treating traumatic brain injury
#163Choline Esters
#164Compositions and methods for treatment of homocystinuria
#165TETHERING CYSTEINE RESIDUES USING CYCLIC DISULFIDES
#166COMPOSITIONS AND METHODS OF TREATMENT OF CORNEAL ENDOTHELIUM DISORDERS
#167Prevention and treatment of benign prostatic hyperplasia using a selective inhibitor of the production of reactive oxygen species of mitochondrial origin
#168Tethering cysteine residues using cyclic disulfides
#169Lipoic acid choline ester compositions and methods of use
#170Tetrahydrocurcumin compositions, methods of making, and methods of using the same
#171Compositions and methods for treatment of homocystinuria
#172COMPOUNDS FOR TREATING NEAR VISION DISORDERS
#173Compounds for the treatment of diseases linked to mitochondrial reactive oxygen species (ROS) production
#174NEUPANEX®: neuroprotective, neuroregenerational, and neurogenesis supporting supplement combination
#175Methods and materials for reducing amyloid beta levels within a mammal
#176Lipid supplements for reducing nerve action potentials
#177Composition for the treatment of metabolic and mechanical neuropathies
#178Compositions And Methods For Immunotherapy
#179Methods and compositions for reversing disruption of the glycocalyx, inflammation, and oxidative damage
#180Fine Dry Particulate Retinoid Active Agent Compositions and Topical Formulations Including the Same
#181SYSTEMS, METHODS, AND FORMULATIONS FOR TREATING CANCER
#182Melatonin for Preventing and Treating Radiation Cystitis
#183Compositions and methods for the treatment of eye disorders
#184Compositions and methods for the treatment and prevention of cognitive decline and preservation of neuronal function
#185Solid pharmaceutical preparation containing lipoic acid and use thereof
#186Method for treating damage induced by sleep deprivation
#187Combinations and methods for the treatment of neuropathic pain
#188Orally administrable compositions comprising avocado/soybean unsaponifiables and lipoic acid and methods of administration
#189CONJUGATE COMPOUNDS OF URSODEOXYCHOLIC, BERBERINE OR L-CARNITINE, AND COMPOSITIONS AND METHODS THEREOF
#190ORALLY ADMINISTERED COMPOSITION FOR TREATING CYSTIC FIBROSIS, COPD, ASTHMA AND OTHER INFLAMMATORY CONDITIONS
#191Compositions Containing Enriched Natural Crocin and/or Crocetin, and Their Therapeutic or Nutraceutical Uses
#192Compositions And Methods For Immunotherapy
#193Pharmaceutical compositions comprising the PPAR agonist INT-131 and Nrf2 activators
#194Dietary supplement formulations for hair
#195Method for stabilization and delivery of therapeutic molecules
#196Compositions and methods for increasing nitric oxide levels for male performance
#197Weight management composition
#198Fatty acid formulations and methods of use thereof
#199Dietary supplement formulations
#200Production method of pregabalin-containing composition and pregabalin-containing composition
#201Compositions for preventing and treating pulmonary injury due to ionizing radiation or cytotoxic drugs
#202PROOXIDANT CANCER CHEMO-SUPPRESSORS AND CHEMO-PROTECTORS AND METHODS OF USE RELATED THERETO
#203Compounds for the treatment of diseases linked to mitochondrial reactive oxygen species (ROS) production
#204Biomarkers for Carcinogenesis and Uses Thereof
#205Antioxidant-Containing Food Composition for Use in Enhancing Antiviral Immunity in Companion Animals
#206Composition for eye health
#207Inhibitors of bacterial two component signal transduction system and uses thereof
#208Methods of detecting and treating a tumor expressing pT346 PDK1
#209Production of water-soluble hydrolyzed clinoptilolite fragments
#210Cancer therapy
#211Method of treating cancer with combinations of histone deacetylase inhibitors (HDAC1) substances
#212Limited release lingual thioctic acid delivery systems
#213ORALLY ADMINISTERED COMPOSITION FOR TREATING CYSTIC FIBROSIS, COPD, ASTHMA AND OTHER INFLAMMATORY CONDITIONS
#214Treatment of addiction and impulse-control disorders using PDE7 inhibitors
#215Compositions and methods for treatment of homocystinuria
#216ALA and salt formulation
#217Detection and treatment of anti-PD-1 therapy resistant metastatic melanomas
#218Oral lipid supplements for treating pain and fibromyalgia
#219Method of noninvasive treatment of diabetic retinopathy
#220Methods and compositions for the treatment of steatosis-associated disorders
#221Delivery system
#222Method for separating cells using immunorosettes and magnetic particles
#223DNA Methylation Landscapes of Post-Traumatic Stress Disorder (PTSD) Susceptibility and Resilience and Novel Therapeutics of PTSD Derived Thereof
#224Methods and compositions for increasing the anaerobic working capacity in tissues
#225LIPOIC ACID CHOLINE ESTER COMPOSITIONS AND METHODS TO GENERATE BIOCOMPATIBLE OPHTHALMIC FORMULATIONS
#226Methods and pharmaceutical compositions for modulating autophagy in a subject in need thereof
#227COMPOSITIONS AND METHODS FOR SKIN CARE
#228DIETARY SUPPLEMENTS AND FORMULATIONS
#229DIETARY SUPPLEMENTS AND FORMULATIONS
#230ALA AND SALT FORMULATION
#231LIMITED RELEASE LINGUAL THIOCTIC ACID DELIVERY SYSTEMS
#232Composition for preventing and/or treating cardiovascular and cerebrovascular diseases
#233Compositions and methods for treatment of homocystinuria
#234Compositions and methods for improving gut health
#235Chemically modified cystathionine beta-synthase enzyme for treatment of homocystinuria
#236Compositions and methods for treatment of prediabetes
#237Compositions and methods for treating traumatic brain injury
#238TREATING MALE INFERTILITY SECONDARY TO SPERM OXIDATIVE STRESS
#239Treatment of addiction and impulse-control disorders using PDE7 inhibitors
#240NOVEL ANGIOTENSIN CONVERTING ENZYME INHIBITOR
#241Compounds for the treatment of diseases linked to mitochondrial reactive oxygen species (ROS) production
#242Tethering cysteine residues using cyclic disulfides
#243Method for the Treatment of Neuropathies and/or Neuropathic Pain
#244Tethering cysteine residues using cyclic disulfides
#245Choline Esters
#246Compositions and Methods for Treating Multi-Drug Resistant Malaria
#247COMPOSITIONS FOR IMPROVING OR MAINTAINING MYOCARDIAL FUNCTION
#248Prevention of symptoms related to fluctuating female hormone levels
#249Method of Treating or Preventing Pathologic Effects of Acute Increases in Hyperglycemia and/or Acute Increases of Free Fatty Acid Flux
#250Pharmaceutical use
#251Combinations of a photosensitizer with a hydrogen sulfide donor, thioredoxin inhibitor or nitroxide for use in photodynamic therapy
#252MODULATION OF CELL FATES AND ACTIVITIES BY PHTHALAZINEDIONES
#253Ophthalmic composition comprising lipoic acid and a mucomimetic polymer
#254BOTULINUM NEUROTOXIN INHIBITORS
#255Use of andrographolide derivatives in preparation of medicaments for preventing and treating inflammatory bowel diseases
#256METHODS AND MATERIALS FOR PROMOTING BONE FORMATION
#257Withaferin compositions for prevention of aging
#258Compositions and methods for treating mitochondrial diseases
#259Formulations of water-soluble derivatives of vitamin E and soft gel compositions, concentrates and powders containing same
#260Combination of lipoic acid and taurine as osmoprotective agent
#261ORAL FORMULATIONS FOR PROMOTING CELLULAR PURIFICATION
#262METHODS AND MATERIALS FOR TREATING CANCER
#263MICRONUTRIENT FORMULATIONS FOR ENVIRONMENTAL EXPOSURE APPLICATIONS
#264Methods and materials for reducing amyloid beta levels within a mammal
#265NUTRITIONAL COMPOSITIONS TO ENHANCE MITOCHONDRIAL ENERGY PRODUCTION
#266Tyrosinase activity inhibitor and external preparation for skin
#267Composition for the treatment of neuropathies and/or neuropathic pain
#268NUTRITIONAL COMPOSITIONS AND ASSOCIATED METHODS
#269System for preparing medicinal beverages using cartridge-type beverage brewers
#270CONJUGATE COMPOUNDS OF URSODEOXYCHOLIC, BERBERINE OR L-CARNITINE, AND COMPOSITIONS AND METHODS THEREOF
#271Methods and compositions for reversing disruption of the glycocalyx, inflammation, and oxidative damage
#272Fine Dry Particulate Retinoid Active Agent Compositions and Topical Formulations Including the Same
#273Conjugates for protection from nephrotoxic active substances
#274METHODS AND COMPOSITIONS FOR UPREGULATING ENDOGENOUS ANTIOXIDANT SYSTEMS
#275METHODS AND COMPOSITIONS FOR REDUCING DAMAGE ASSOCIATED WITH OXIDATIVE PHOSPHORYLATION
#276Methods and compositions for supporting endogenous systems related to life span
#277Compositions for Preventing and Treating Pulmonary Injury due to Ionizing Radiation or Cytotoxic Drugs
#278Methods and compositions for the treatment of pre-diabetes, diabetes and metabolic syndrome
#279Compositions and methods for skin care
#280Chewable lipid supplements for treating pain and fibromyalgia
#281Compositions and Methods for Treatment of Prediabetes
#282Nutritional supplements for improving female fertility
#283MATERIALS AND METHODS FOR TREATMENT AND DIAGNOSIS OF DISORDERS ASSOCIATED WITH OXIDATIVE STRESS
#284Pet Food Compositions Including a Sustained-Release Lipoic Acid and Methods of Manufacture and Use Thereof
#285Method for reducing damage caused by free radicals
#286Methods and compositions for inhibiting and treating neurological conditions
#287COMPOSITION FOR PREVENTING OR TREATING OBESITY CONTAINING ALPHA-LIPOIC ACID AND N-ACETYLCYSTEINE AS ACTIVE INGREDIENTS
#288Hydroxy aliphatic substituted phenyl aminoalkyl ether derivatives
#289Composition for the prevention and treatment of metabolic disorders associated with menopause and climacteric
#290Composition for the treatment of neuropathies and/or neuropathic pain
#291Optical correction
#292Dietary supplement compositions for cardiovascular health
#293USE OF ASPARAGUSIC ACID AND DERIVATIVES THEREOF TO TREAT SYMPTOMS AND DISORDERS OF NEUROLOGICAL DISEASE
#294APPLICATION OF COMPOUND MIXTURES TO CONTROL OXIDATION
#295Emulsion of Carotenoids and Ocular Antioxidants
#296BUTYROYLOXYMETHYL DIETHYL PHOSPHATE COMPOUNDS AND USES THEREOF
#297THERAPEUTIC COMPOSITIONS INCLUDING THERAPEUTIC SMALL MOLECULES AND USES THEREOF
#298Fatty acid formulations and methods of use thereof
#299Antioxidant-Containing Food Composition for Use in Enhancing Antiviral Immunity in Companion Animals
#300Method for stabilization and delivery of therapeutic molecules